Trial Profile
A Retrospective Safety Data Collection Registry of VivitraTM (Trastuzumab) - VivitraTM Registry
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer; Early breast cancer; Gastric cancer
- Focus Therapeutic Use
- Sponsors Zydus Lifesciences
- 22 Jun 2018 New trial record